EdgeMarketInstruments › AGEN

AGEN — AGENUS INC

US Healthcare Pharma & biotech equity mkt cap 364.2M
8.09 +8.01% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 2.77 · high 8.30

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+8.01%
1 week+10.52%
1 month+30.69%
3 months+156.01%
6 months+164.38%
Year to date+150.46%
1 year+79.38%
3 years-67.90%
5 years-93.42%

Technicals

RSI 1452.6
vs 50-day avg+52.73%
vs 200-day avg+100.57%
Volatility 1y118.2%
Max drawdown 1y-45.36%
Avg volume 30d7.9M
Daily bars held2,674
History from2016-01-04

Measured signals that fired on AGEN

datesignal measured base rate
2026-08-04Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-07-28Breakout to a 52-week high
price
-1.00% over 21 days · t = -8.58 · n = 24,386
statistically distinguishable from its control group
2026-07-13Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group
2026-06-25Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-07-10ARMEN GARO H
See Remarks
Grant or award4.9K3.3516.3K
2026-07-01HARRISON THOMAS L
Director
Grant or award8.5K3.5830.6K
2026-06-26ARMEN GARO H
See Remarks
Grant or award5.4K3.0316.3K
2026-06-12ARMEN GARO H
See Remarks
Grant or award4.9K3.3016.3K
2026-05-29ARMEN GARO H
See Remarks
Grant or award4.6K3.5016.3K
2026-05-15ARMEN GARO H
See Remarks
Grant or award4.5K3.5816.3K
2026-05-01ARMEN GARO H
See Remarks
Grant or award4.2K3.8416.3K
2026-04-17ARMEN GARO H
See Remarks
Grant or award3.4K4.7916.3K
2026-04-03ARMEN GARO H
See Remarks
Grant or award4.6K3.3315.4K
2026-04-01HARRISON THOMAS L
Director
Grant or award9.2K3.3230.6K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
VANGUARD CAPITAL MANAGEMENT LLC4.8M1.4M
VANGUARD PORTFOLIO MANAGEMENT LLC4.0M1.2M
Siren, L.L.C.3.6M1.1M
MARSHALL WACE, LLP2.3M688.2K
BlackRock, Inc.1.8M545.7K
GEODE CAPITAL MANAGEMENT, LLC1.2M348.4K
MORGAN STANLEY988.0K295.8K
RENAISSANCE TECHNOLOGIES LLC954.1K285.6K
Man Group plc931.8K279.0K
RAYMOND JAMES FINANCIAL INC800.1K239.6K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d54.7% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about AGEN

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open AGEN in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →